Weighing the outcomes.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 18259169.
- Also identified by DOI 10.1038/nbt0208-173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The emergent healthcare value era, its consequences, and what drug firms need to do about it.
Medical subject headings
- Biological Products
- Biotechnology
- Industry
- Marketing
- Pharmaceutical Preparations
- Risk Assessment